Home linkHome link

Publications

You are currently filtering by: 2019 Cancer liver

• 2019 • Journal of Pharmacy and Pharmacology
Resveratrol glucuronidation in vitro: potential implications of inhibition by probenecid

Matin B1, Sherbini AA, Alam N, Harmatz JS, Greenblatt DJ

Full Article
• 2019 • Cancer Science
Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway

Hara M, Takeba Y, Iiri T, Ohta Y, Ootaki M, Watanabe M, Watanabe D, Koizumi S, Otsubo T, Matsumoto N

Full Article

NDRI is a Not-For-Profit (501c3) Corporation.

National Disease Research Interchange logo
National Disease Research Interchange

Three Parkway
1601 Cherry Street, Suite 1700
Philadelphia, PA 19102

CAP Accredited Registered scientist.com supplier

General

info@ndriresource.org


Researchers

research@ndriresource.org

 

Privacy Policy

Main

(215) 557-7361